Hilltop National Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$724K Buy
5,081
+3,121
+159% +$473K 0.16% 122
2026
Q2
$307K Hold
1,960
– – 0.07% 190
2026
Q1
$299K Buy
1,960
+1,560
+390% +$239K 0.07% 186
2025
Q4
$55.1K Sell
400
-138
-26% -$18.1K 0.01% 437
2025
Q3
$69K Hold
538
– – 0.02% 407
2025
Q2
$65.1K Buy
+538
New +$60.6K 0.02% 416
2024
Q4
$38.9K Hold
400
– – 0.01% 472
2024
Q3
$46K Hold
400
– – 0.01% 475
2024
Q2
$42.6K Hold
400
– – 0.01% 481
2024
Q1
$38.7K Buy
+400
New +$41K 0.01% 484

Other funds holding NVS

Hilltop National Bank's NVS Position: Q3 2026 in Review

Hilltop National Bank increased its Novartis (NVS) stake by 159% in Q3 2026, buying an estimated $473K and bringing the position to 5,081 shares worth $724K. The position accounts for 0.16% of the portfolio, ranked #122.

Hilltop National Bank first reported a position in NVS in Q1 2024 and has held it in 10 quarters since. 235 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Hilltop National Bank held 5,081 shares of Novartis worth $724K as of Q3 2026.
  • Hilltop National Bank bought 3,121 Novartis shares in Q3 2026, an estimated $473K.
  • Novartis made up 0.16% of Hilltop National Bank's portfolio in Q3 2026, its #122 holding.
  • Hilltop National Bank first reported a position in Novartis in Q1 2024 and has held it in 10 quarters since.
  • 235 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Hilltop National Bank's 13F filing for Q3 2026, filed 14 Oct 2026.